Skip to main content

and
  1. Article

    Open Access

    Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis

    There is still no approved medication for the core symptoms of autism spectrum disorder (ASD). This network meta-analysis investigated pharmacological and dietary-supplement treatments for ASD.

    Spyridon Siafis, Oğulcan Çıray, Hui Wu, Johannes Schneider-Thoma in Molecular Autism (2022)

  2. Article

    Open Access

    Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis

    Placebo response in autism spectrum disorder (ASD) might dilute drug-placebo differences and hinder drug development. Therefore, this meta-analysis investigated placebo response in core symptoms.

    Spyridon Siafis, Oğulcan Çıray, Johannes Schneider-Thoma in Molecular Autism (2020)

  3. No Access

    Article

    Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis

    Negative symptoms are the core of schizophrenia, but whether antipsychotics are efficacious for their treatment is unclear. Moreover, there is debate whether patients in relevant trials should have predominant...

    Marc Krause, Yikang Zhu, Maximilian Huhn in European Archives of Psychiatry and Clinic… (2018)